Sickness-associated anorexia : mother nature’s idea of immunonutrition? by Van Niekerk, Gustav et al.
Review Article
Sickness-Associated Anorexia: Mother Nature’s
Idea of Immunonutrition?
Gustav van Niekerk, Ashwin W. Isaacs, Theo Nell, and Anna-Mart Engelbrecht
Department of Physiological Sciences, Private Bag X1, Matieland, Stellenbosch 7600, South Africa
Correspondence should be addressed to Gustav van Niekerk; gustav.v.niekerk@gmail.com
Received 1 April 2016; Revised 13 June 2016; Accepted 14 June 2016
Academic Editor: William Festuccia
Copyright © 2016 Gustav van Niekerk et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
During an infection, expansion of immune cells, assembly of antibodies, and the induction of a febrile response collectively place
continual metabolic strain on the host.These considerations also provide a rationale for nutritional support in critically ill patients.
Yet, results from clinical and preclinical studies indicate that aggressive nutritional support does not always benefit patients and
may occasionally be detrimental. Moreover, both vertebrates and invertebrates exhibit a decrease in appetite during an infection,
indicating that such sickness-associated anorexia (SAA) is evolutionarily conserved. It also suggests that SAA performs a vital
function during an infection. We review evidence signifying that SAA may present a mechanism by which autophagic flux is
upregulated systemically. A decrease in serum amino acids during an infection promotes autophagy not only in immune cells,
but also in nonimmune cells. Similarly, bile acids reabsorbed postprandially inhibit hepatic autophagy by binding to farnesoid X
receptors, indicating that SAA may be an attempt to conserve autophagy. In addition, augmented autophagic responses may play
a critical role in clearing pathogens (xenophagy), in the presentation of epitopes in nonprovisional antigen presenting cells and
the removal of damaged proteins and organelles. Collectively, these observations suggest that some patients might benefit from
permissive underfeeding.
1. Introduction
Infection or tissue trauma is known to induce a range of
behavioural modifications collectively referred to as sick-
ness behaviour. Of all these behavioural changes, sickness-
associated anorexia (SAA) represents a paradox.Mobilisation
of an immune response is metabolically costly [1]. The pro-
duction of antibodies as well as other signalling peptides (e.g.,
cytokines and initial phase proteins), expansion of immune
cell populations, and the induction of a febrile response all
contribute towards a dramatic increase in the demand for
metabolic substrates. Yet, despite the cost associated with
mobilising an immune response, a decrease in appetite man-
ifests as one of the most cardinal symptoms of an established
infection.
Three observations suggest that such SAA represents an
adaptive response. Firstly, noninfectious elements such as
lipopolysaccharides (LPS) or certain cytokines (e.g., Il-1𝛽 and
TNF-𝛼) induce appetite loss [2].The fact that SAA is engaged
by the same canonical inflammatory mediators released in
response to infection suggests that SAA forms part of the
immune response. Secondly, an array of animals, ranging
from vertebrates [3–6] to invertebrates [7–10], all exhibit
SAA. Indeed, even primitive animals such as sea anemones
retract tentacles and stop feeding after a pathogen chal-
lenge [11], indicating that SAA may indeed be evolutionary
ancient and conserved across numerous species. In turn, such
prevalence amongst animals suggests that SAA must impart
a significant fitness advantage. Finally, SAA is consistently
observed in a variety of contexts. Only African horse sickness
(a lethal vector-borne equine viral infection) is known to
induce a fever without inducing an anorexic response [12].
Similarly, a recent review highlighted a number of social fac-
tors (e.g., maternal care for the young or guarding behaviour
against intruding males) which may attenuate aspects of
sickness behaviour [13]. Yet, strikingly, no examples where
anorexia is diminished have been identified. Taken together,
these observations support the view that SAA is a dedicated
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host response that facilitates host survival during an infec-
tion, though themechanism bywhich SAA imparts a survival
advantage remains elusive.
A number of theories have been forwarded to explain
the adaptive value of SAA. Since free iron is rapidly reduced
during an infection [14, 15], it has been argued that chronic
low iron levels might provide a pleiotropic benefit by pro-
tecting the host against infections [16]. Consequently, an
anorexic response may deny pathogens critical resources
such as iron [15]. However, recycling of endogenous reserves
(e.g., haemoglobin) represents the primary mechanism by
which iron levels are maintained, with dietary reabsorption
being highly ineffective. In fact, less than 1% of dietary iron
is absorbed, with iron status responding only slowly to a
changing nutritional status [17]. Aligning behavioural aspects
with immunological prerogatives has also been proposed
as a physiological strategy pursued by sickness-associated
anorexia. In conjunction with a general sense of fatigue,
anorexia may decrease an animal’s motivation for engaging
in foraging behaviour [12]. Also, foraging animals expose a
larger surface fromwhich theymay radiate heat, thus limiting
the efficacy of a febrile response [12]. In addition, infected
animals may be less attentive to their surroundings [12] or
more conspicuous [18] and accordingly under greater risk of
predation.Thus, decreasing foraging activities would possibly
reduce exposure to predators. Furthermore, since many
pathogens gain entry via the oral route, anorexia may prevent
exposure to a fatal pathogen load [12]. Yet, although LPS
administration dramatically decreases food intake in rats,
hoarding behaviour seems only modestly reduced if under
restricted food access (30min/day) [19]. In fact, Siberian
hamsters (which are dedicated hoarders, unlike house mice
and rats) injected with LPS demonstrate a dramatic decline
in feeding, while hoarding behaviour remains mostly intact
[20]. Consequently, it remains to be explained why an animal
would demonstrate hypophagia as an energy-conserving or
predation-avoiding strategy but remains actively foraging.
We recently argued [21] that a reduced appetite during an
infection may represent an evolutionary conserved strategy
for systemically upregulating another evolutionary conserved
process, autophagy. A brief overview of the ambiguous results
on studies investigating the benefit of nutritional support in
critically ill patients is provided, followed by an overview of
the nutritional context of immune cells during an infection.
Next, a summary of the various mechanisms by which
an increase in autophagic activity may influence clinical
outcome is provided.This is followed by a discussion address-
ing some of the key limitations of SAA as an inducer of
autophagy, with reference to the clinical implication for nutri-
tional support. Finally, we address outstanding questions
regarding the role of autophagy, and how insight into these
considerations may lead to more refined nutrition support
protocols.
2. Is Nutritional Support Beneficial?
A major goal of nutritional support in critically ill patients is
to avoid the loss of muscle mass, a clinical marker for mortal-
ity and morbidity. Yet, various lines of evidence suggest that
nutritional support may not provide any benefit, and indeed,
may potentially be harmful in certain contexts. In a rat model
of septic shock, “immunonutrition” with polyunsaturated
fatty acids or arginine aggravated disease progression [22].
Similarly, nutritional intervention has not consistently been
demonstrated to be effective in critically ill patients. Indeed, it
was found in one study that patients receiving early parenteral
nutrition (on day 3 in the intensive care unit) had a small but
significantly higher incidence of infection [23] while another
study showed a decrease in mortality associated with per-
missive underfeeding (60–70% of caloric goal) [24]. A recent
Cochrane meta-analysis reported that the only benefit asso-
ciated with nutritional therapy is a decrease in nonelective
readmission [25]. Indeed, a consortium of experts have advo-
cated that permissive underfeeding rather than full caloric
feeding should be applied to critically ill patients suffering
sepsis or septic shock [26]. Yet, the mechanism by which a
decrease in nutritional intake would be beneficial remains
to be fully elucidated.
A similarly puzzling phenomenon is the paradoxical
benefit observed during short-term fasting: starvation, up to
three days prior to Listeria challenge, reduced the mortality
rate to only 5% (compared to a fed groupwith amortality rate
of 95%) [27]. In addition, starvation promoted macrophage
activity against bacteria such as Listeria monocytogenes (both
in vivo and in vitro), which could be further enhanced by
LPS administration [28]. M. J. Murray and A. B. Murray [29]
also recount an interesting anecdote provided by Edward [30]
who noticed that starved hedge-hogs seemed immune to foot
andmouth disease. Correspondingly, force-feeding during an
infection resulted in a highermortality rate among mice [29].
Thus, there is both clinical and preclinical evidence indicating
that nutritional support does not benefit all patients.
3. Starvation: A Calculated Response
It is widely accepted that starvation potently inhibits immune
function [31], suggesting that SAA may impede the mobil-
isation of an effective immune response. Yet, animals have
evolved a range of adaptations to cope with nutrition stress
[32]. Immune cells in particular occupy a privileged position
with regard to the provision of energy-dense substrates.
Indeed, during an infection, the expansion of immune effec-
tors is fuelled by peripheral catabolism. In this regard, a
number of physiological adaptations ensure that, despite a
decrease in feeding, the immune system does not become
nutrient deprived.
3.1. Energy-Rich Metabolites and Paracrine Signalling. Acti-
vated immune cells are highly dependent on glucose. Indeed,
hypoxia-inducible factor (HIF), amajor inducer of glycolysis,
is necessary for macrophage maturation [33]. Conversely, a
switch towards oxidative metabolism is accompanied by an
activation of an anti-inflammatory programme [34]. It must
be noted that although glycolysis is usually active during
hypoxia, activated immune cells, similar to other rapidly
dividing cells such as cancer cells and proliferating fibroblasts,
engage in a form of oxidative glycolysis: these cells produce
ATP via glycolysis irrespective of oxygen tension. Such
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aerobic glycolysis (Warburg effect), which is less efficient
than oxidative phosphorylation, is likely explained by two
possible factors [35]. First, the inefficiency of glycolysis is
compensated for by the rapid speed by which a cell can
generate ATP via glycolysis. Second, metabolic intermediates
of glycolysis are easily fluxed into biosynthetic pathways
that are also upregulated in rapidly dividing cells. As an
example, the acetyl-CoA which is required for the synthesis
of fatty acids is derived from glycolytic pathway. In this
regard, the synthesis of fatty acids is critical for immune
cell function. In fact, compromising the ability of monocytes
to synthesise fatty acids prevents differentiation into mature
macrophages [36]. The dependency of fatty acid synthesis is
in turn explained by the demand for phospholipid synthesis:
an expansion of cellular components such as endoplasmic
reticulum (ER), mitochondrial network, lysosomes, and the
development of filopodia all make it necessary for lipids to be
incorporated into membrane structures [36]. Thus, activated
immune cells require glucose for energy production as well
as for the biosynthesis of cellular components. It is thus likely
that the Warburg effect can be explained by the fact that
glycolysis intersects both energy production and biosynthe-
sis.
A number of key regulatory factors ensure that immune
cells are also well supplied with glucose. Proinflammatory
cytokines TNF [37] and IL-1𝛽 [38] induce insulin resistance
and thus elevate blood glucose levels. In turn, high glucose
levels facilitate the influx of glucose into immune cells via
GLUT-1 transporters. Since a GLUT-1 transporter is a facil-
itative transporter, intracellular glucose is dependent on the
extracellular glucose concentration. Thus, elevated glucose
levels during an infection are likely to be an adaptive strategy
to ensure adequate glucose content in activated immune cells.
Similarly, a severe infection is often associated with hyper-
triglyceridemia. In rats, even low doses of LPS rapidly induce
hypertriglyceridemia [39]. High triglyceride levels are main-
tained through de novo synthesis in the liver [39] and release
from adipocytes [40]. Similarly, the development of insulin
resistance by LPS binding to TLR4 [41] leads to the secretion
of inflammatory cytokines that induce a state of insulin
resistance [42]. Thus, infection results in the liberation of
energy-richmolecules in circulationwhich drive immune cell
metabolism.
Adipose tissue also seems to be functionally integrated
with the immune system, particularly adipocytes which are
anatomically associated with lymphoid tissue [43–46]. Since
mobilisation of an immune response is costly, special mech-
anisms exist to suppress immune function during nutrient
stress, for example, leptin acting as an “immune-trophic” fac-
tor by signalling energy status and thus allowing the optimi-
sation of an immune investment within context of metabolic
reserves [47]. In fact, even short-term fasting is able to
decrease leptin levels [48]. In this regard, the finely branched
lymph vessels increase surface area [44, 45], which facilitates
local supply of energy-rich molecules as well as adipocyte-
derived paracrine factors [43–45, 49]. Such local paracrine
signalling may play an important role during fasting. The
finely branched lymph vessels permeating through local
adipose deposits represent an anatomical adaptation that
may also facilitate paracrine signalling factors between
adipocytes and immune cells [43–45, 49]. Supporting this
view, adipocytes associated with lymphoid tissue do not
respond to normal fasting cues but instead are more sensitive
to immune signals, suggesting that these cells are dedicated to
assisting immune cells [43–46, 49]. Similarly, bone marrow
fat (BMF), whose function remains largely unknown, may
function as a “paracrine factory,” sustaining local immune
cells even in the face of low nutrient availability. Indeed,
BMF is highly unresponsive to fasting and exhibits a para-
doxical increase in anorexic patients [50]. It is tempting to
speculate that an increase of BMF during anorexia (and aged
individuals [51]) may be an attempt to counteract immune-
antagonising signalling context. The fact that BMF cells are,
unlike normal adipocytes, not conglomerated but in fact
interspersed, indicating a potential paracrine rather than
storage function, supports this view [52]. Finally, ovarian
cancer cells metastasising to the omentum (a “sail” of adipose
tissue, permeated with lymph vessels) were found to be
“fuelled” by adipocytes that directly transfer lipids to cancer-
ous cells [53].Though these authors identified beta-oxidation
as a likely endpoint of the fatty acids, it is also likely that the
fatty acids derived from these cellsmay be involved in the syn-
thesis of cellular components. It is likely that these lymphoid-
associated adipocytes may respond to signalling queues usu-
ally presented by activated immune cells, which are coopted
by cancer cells.
These aforementioned observations suggest that adipo-
cytes may play a critical immune-supporting role by provid-
ing energy-rich substrate for both biosynthesis and energy
production, as well as paracrine factors for sustaining an
immune response within a fasted state. Furthermore, recent
findings indicate that the close cooperation between the
immune system and adipocytes might extend beyond the
simple task of supplying energy-richmolecules and paracrine
factors. As an example, adipocytes are known to generate
antimicrobial peptides [54] and exhibit a phagocytic capacity
[55] and since adipocytes can express MHC II [56], they
possibly also play a role in epitope expression. It is thus
evident that adipocytes are functionally integrated with the
immune system. Indeed, it has previously been argued that
the advent of adipocytes, a tissue unique to vertebrates [57],
may have allowed the evolution of an adaptive immune
system [58]. These adaptations ensure that fasting during an
infection would, in an otherwise healthy and well-nourished
individual, not impede immune function.
3.2. An Altered Amino Acid Profile Leads to an Upregulation
of Autophagy. In contrast to glucose and lipids, it has long
been recognised that the plasma levels of most amino acids
(AAs) undergo a marked decline during a range of different
infections or sterile tissue damage [59–64]. Of note, AA levels
are in a dynamic state, often exhibiting a rebound effect and
are most likely influenced by the severity of an infection
or simulation thereof, as well as the time point at which
serum AA levels are sampled. Such a decrease in AA occurs
in the context of rapid muscle catabolism, suggesting the
prime recipients of liberated amino acids may be the liver,
where amino acids are used in gluconeogenesis, and immune
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cells for rapid cell division or anabolism. The observation
that serum levels of branched chain AA (BCAA) often
decrease during an infection [60, 65–67], in conjunction
with ex vivo studies demonstrating the ability of leucine to
inhibit muscle degradation [68], initially generated much
excitement as a potential supplement in septic patients. Since
critically ill patients exhibit an increase in protein turnover
[69], these observations suggest that AA supplementation
would be beneficial to critically ill patients. However, results
from studies applying supplementation with these or other
amino acids have been disappointing and there is currently
no definitive study that demonstrates the optimum protein
provision in critically ill patients [70].
Low AA profiles during an infection thus raise two
questions. Firstly, it remains to be explained why AA supple-
mentation, despite the decline in plasma levels of various AA
levels at some point during an infection, failed to consistently
demonstrate clinical benefit. Secondly, the reason why vari-
ous AAs decline at some point during an infection is peculiar,
given the fact that a range of other sophisticated adaptations
exist to supply immune cells with energy-rich substrates for
energy production and biosynthesis.
4. SAA as an Inducer of Autophagy
4.1. SAA Promotes Upregulation of Autophagy. All eukaryotic
cells, when starved of nutrients, activate an ancient catabolic
process known as autophagy. Autophagy (derived from the
Greek words automeaning “self” and phagymeaning “eat”) is
an evolutionary conserved process by which eukaryotic cells
degrade large cellular components into substrates that sub-
sequently can be either used as fuel source, or utilised for the
synthesis of critical cellular components.Whereas the protea-
somedegrade proteins, autophagy is used in bulk degradation
of cytoplasmic components, including organelles such as
mitochondria or long-lived proteins (process formally known
as macroautophagy). Autophagy is rapidly upregulated in
starved cells derived from a range of eukaryotes, including
plants [71], yeasts [72], invertebrates [73], andmammals [74].
The autophagic process is critical for cell survival during
nutrient stress. Transgenic mice with defective autophagic
process develop normally but die shortly after birth [75].
Remarkably, it was established that defects in autophagy
resulted in these mice being unable to maintain nutrient
homeostasis during the transition from placental nutrition
to feed-fasting cycles associated with suckling, thus clearly
demonstrating the pivotal role of autophagy supplying nutri-
ents during fasting. The evolutionary conserved process of
autophagy thus plays a critical role in regulating cellular
nutrient status in a fasted state, where it is consistently and
robustly upregulated during periods of fasting.
The mechanism by which nutrient stress can induce
autophagy has recently been reviewed [76, 77]. Briefly,
autophagy is inhibited by mTOR and upregulated by AMPK.
A low ATP : ADP ratio results in the activation of AMPK.
In turn, activated AMPK inhibits mTOR, a major inhibitor
of autophagy. Low energy status is thus one mechanism by
which autophagy is upregulated. In this regard, cytokine-
mediated insulin resistance may represent a strategy to
induce low levels of energy stress in cells, prompting upreg-
ulation of autophagy; alternatively, an increase in the cellular
AA pool results in the activation of mTOR and a subsequent
inhibition of autophagy. As an example, supplementation
with BCAA such as leucine protects against muscle wasting
induced by a protein-deficient diet [78]. Of note, these
authors implicate a decrease in protein degradation, rather
than synthesis as the mechanism by which leucine pro-
tects muscle mass during AA starvation. This study again
emphasises the ability of nutrients such as AA to potently
inhibit autophagy. Additionally, depletion of AAs results in
the accumulation of unchanged tRNA which in turn also
induces autophagy [79]. Finally, under conditions of nutrient
deficiency, cells utilise amino acids as a source of energy
andmetabolic waste products, such as ammonia, accumulate.
In this regard, ammonia has also been shown to induce
autophagy, but by an mTOR-independent mechanism [80].
Starvation is not the only trigger for autophagy (Figure 1).
As an example, ER stress also induces the activation of
autophagy [81], where autophagy provides a mechanism
for degrading misfolded protein aggregates that cannot be
accommodated by the proteasome. In fact, a range of cellular
insults including free radicals [82], heavy metals [83], or
cytotoxic chemotherapeutics [84] induce autophagy as a gen-
eral stress response. Also, autophagy is regulated by growth
factors [85]. Singling pathways activated by growth factors
can directly inhibit autophagy (e.g., Ras activation [86]).
Conversely, growth factor withdrawal causes a decreased
expression of major nutrient transporters on cell surface,
resulting in a decrease in intracellular nutrients, thus leading
to the activation of autophagy by nutrient stress. Finally,
autophagy is a selective process, being able to target substrates
for degradation. As an example, autophagy has been shown to
selectively target damaged mitochondria (i.e., mitochondria
with a lowmembrane potential) for degradation, thus playing
an important role in mitochondrial “quality control” [87] (a
process referred to as mitophagy). The fact that the catabolic
process of autophagy can selectively target substrates for
degradation also positions autophagy for another key cellular
process: host defence against intracellular pathogens. In fact,
autophagy is also involved in the degradation of pathogens
(formally known as xenophagy) [88].
Therefore, a plausible relationship exists between SAA as
a mechanism for upregulating autophagy and the antimicro-
bial function of autophagy. In fact, the altered AA profile
seen in patients may represent a mechanism by which AA
withdrawal inhibits mTOR, with a subsequent increase in
autophagy. Interestingly, depriving macrophages of growth
factors and AAs for four hours upregulated autophagy and
provided added protection againstMycobacterium tuberculo-
sis (TB) [89].This suggest that upregulating macroautophagy
through fasting can augment immune function.
4.2. The Role of Autophagy during an Infection and Tissue
Trauma. In previous work, we argued that autophagy has a
number of critical functions during an infection [21] (Fig-
ure 2). As an example, a higher rate of autophagic flux would
confront intracellular pathogens with a shorter time frame
for manipulating the host’s intracellular defences. Similarly,
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Figure 1: Autophagy plays a key role in energy homeostasis, immune regulation, and a generic stress response to various insults. Growth
factor signalling is known to inhibit autophagy directly but may also influence autophagy indirectly, by controlling the cellular import system
for AAs. High levels of AAs (in particular, essential AAs such as the BCAA, leucine) also inhibit autophagy through activation of mTOR. In
contrast, low energy status upregulates AMPK, which in turn inhibits mTOR, resulting in an increase in autophagy. Autophagy can also be
activated by immune effectors includingTLR-4 activation or alarmins or via cytokine such as Il1-b and IFN-𝛾. Also, autophagymodulates these
inflammatory mediators, for example, by degrading the inflammasome. Finally, autophagy as a generic stress response is also upregulated
under hypoxic conditions, or in response to oxidative stress.
pathogens have evolved mechanisms for inhibiting apopto-
sis in response to viral subversion of genomic replication
machinery [90]. In this regard, autophagy-mediated cell
death (autosis) [91] may provide a “backup” cell death
programme. In addition, a range of prominent autophagic
mediators (e.g., BECN1, ATG5, ATG7, and ATG12) are also
involved in apoptotic pathways [92], suggesting that upreg-
ulation of autophagy may “prime” cells for cell death. This
would also suggest that SAA may be a protocol not only
for enhancing the antipathogen activity of immune cells,
but also for cell-autonomous defences, thus obstructing the
spread of infectious agents. Finally, autophagy is involved
in the expression of epitopes in nonprofessional antigen-
presenting cells such as muscle [93], endothelium [94], and
adipocytes [54], suggesting that SAA-induced autophagymay
augment immune operations by recruiting nonimmune cells
in mobilising an adaptive immune response. Supporting this
view, inhibition of mTOR, a potent initiator of autophagy,
enhances the efficacy of influenza vaccine in mice [95]. Simi-
larly, viral inhibition of the proteasome pathway, a strategy to
prevent cells fromprocessing and expressing viral epitopes on
MHC I, can be compensated for by autophagic processing of
endogenous proteins [96].
Moreover, autophagy may also enhance host survival via
the nonimmune mechanism. A severe inflammatory episode
challenges cells with a number of insults that must be dealt
with. Indeed, the development of clinical hypothermia in
severe cases of sepsismay be a strategy to avoid overwhelming
of cellular survival systems. Supporting this view, in a rat
model of severe endotoxemia, rats that were allowed to
develop hypothermia (an observation often seen in cases
of severe systemic inflammation) demonstrated a significant
increase in survivability [97]. Autophagy as a generic cell sur-
vival response may play a critical role in addressing the stres-
sors imposed by a systemic inflammatory context. Indeed,
insufficient autophagy in rabbits suffering severe burns has
been implicated in mitochondrial dysfunction and organ
failure [98]. In addition, autophagy may play a role in
clearing phagocytosed apoptotic bodies [99], thus avoiding
secondary necrosis and subsequent inflammation. Further-
more, autophagy is also implicated in the degradation of
the inflammasome complex [100], thus controlling inflam-
matory tone and rendering cells more responsive to the
disease trajectory. Finally, an increase in body temperature
within a fever range induces the expression of heat shock
proteins [101], suggesting that newly synthesised proteinsmay
occasionally be misfolded. In this regard, autophagy may
play an important role in degrading aggregates of misfolded
proteins [102]. In summary, it is evident that autophagy is
involved in both pathogen clearance and host survival during
an infection.
5. Fasting-Induced Autophagy:
A Double-Edged Sword?
Host-pathogen coevolution results in the constant develop-
ment of novel immunological strategies by host, which in
turn place evolutionary pressure on pathogens to develop
effective counter-measures [103]. In this regard, the fact
that autophagy is also upregulated by immunological signals
such as LPS and TNF [104] not only emphasises the role
of autophagy within an immunological context, but also
suggests that pathogens coevolved with the autophagic pro-
cess as a host defence mechanism. Indeed, pathogens have
evolved a number of strategies to subvert the autophagy
process [105]. This suggests that fasting may be a strategy
to upregulate autophagy as a result of an escalating “arms
race” between host and pathogens: by invoking fasting condi-
tions, autophagy is synergistically activated by two indepen-
dent pathways (immunological activation as well as fasting-
induced autophagy). Such a dual activation (by fasting cues
and immunological signalling cascades) may render the
autophagic process more resistant to “singling attacks” by
pathogens attempting to subvert or inhibit autophagy.
However, some pathogens have not only evolved suc-
cessful measures for subverting host autophagic machinery.
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Figure 2: Autophagy plays a critical role in pathogen clearance and host survival. The fibril response as well as oxidative stress resulting
from tissue ischemia or immune activation may damage proteins which in turn form toxic aggregates which are cleared by autophagy
(“aggrephagy”). Similarly, damaged and dysfunctional mitochondria are targeted for cellular digestion (mitophagy), thus optimising energy
generation while diminishing ROS production. Autophagy is also involved in the clearance of intracellular pathogens (xenophagy) in
both immune and nonimmune cells. Not demonstrated, autophagic processes are also involved in epitope expression and may provide an
alternative form of cell death in viral-infected cells. Also, autophagy maymodulate the inflammatory tone by possessing membrane receptors
and singling platforms such as the inflammasome.
This is well exemplified byTrypanosoma cruzi.The pathogen’s
internalisation intomouse embryonic fibroblasts is hampered
by deletion of key autophagic proteins, Atg5 and Beclin 1, and
similarly is promoted by conditions that enhance autophagy
(inhibition of mTOR by both rapamycin and AA starvation)
[106]. This indicates that upregulation of autophagy may
promote the growth of Trypanosoma cruzi. In fact, these
authors point out that the disease course of T. cruzi infections
may be adversely affected by the nutritional state of infected
individuals: in undernourished individuals, with high rates of
hepatic autophagy, the growth of Trypanosoma cruzimay be
enhanced. Therefore, it is likely that similar clinical contexts
exist in which nutritional support may be implemented in
mediating therapeutic inhibition of autophagic processes.
Furthermore, aggressive nutritional support may be
necessary in patients who are already undernourished. As
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mentioned earlier, leptin plays a key role in maintaining
immune function. In fact, leptin expression is also markedly
increased in response to an immune challenge [107]. Con-
versely, mice lacking leptin or leptin receptors exhibit defects
in their immune function [108]. In this regard, leptin levels
parallel body fatmass, indicative of long-termnutritional sta-
tus [109]. In undernourished individuals, chronically low lep-
tin levels have been implicated in the immune insufficiency
observed in these individuals.Thus, a physiological difference
between fasting and starvation is a key point that needs to be
investigated. Nutritional state prior to an insult may play a
critical role in targeting patients that would benefitmost from
nutritional support, and those who would tolerate permissive
underfeeding with a more favourable outcome.
This also points to another key aspect of nutritional
support, namely, the timing of nutritional intervention. As
argued here, maintaining high levels of autophagy may be
advantageous during the initial phases of an infection or
injury. However, during the resolution phase, nutritional
support may become crucial in sustaining anabolic repair
processes. Supporting this view, a recent study in critically
ill children [110] has demonstrated superior outcome with
late (postponed by 1 week) parenteral nutrition, reaffirming
an observation also made for adults [23, 111]. A contributing
factor is the possibility that withholding parenteral nutrition
during the early phase of an injury/infection may promote
higher levels of autophagy when it is most beneficial. In
contrast, nutritional supplementation may be more advanta-
geous during the resolution phase, when macronutrients are
required for effective tissue repair.
The ambiguous results from clinical trials suggest that
some patients may benefit from nutritional support whereas
others may in fact be negatively affected by nutritional inter-
ventions. Clinical trials are often performed on “critically
ill” patients without distinguishing between the nature and
the cause of the illness. Reevaluating clinical benefit in the
context of different disease settings may point out the context
in which preservation of autophagic processes may be more
important than supplying metabolic substrates. There is also
a need to develop good markers for mapping the disease
trajectory, thus allowing for optimised nutritional protocols
where nutrients are administeredwhen they are neededmost.
6. Future Directions
The role of autophagy during an infection, and possibly
also in the context of tissue trauma, highlights a number of
issues regarding the role of nutritional therapy in critically ill
patients. Nutritional support increases circulating AA levels
which inhibit autophagy. Similarly, the secretion of bile salts
in response to a meal also inhibits hepatic autophagy. This
raises the question whether dietary formulation could be
designed to supply patients with nutrients without inhibiting
autophagic processes. As mentioned previously, bile acids
that are reabsorbed after a meal inhibit hepatic autophagy.
This would suggest that enteral nutritional formulations
that avoid extensive bile flow may avoid downregulation of
autophagy. Bile acid release is initiated by the gastric peptide
hormone cholecystokinin, which is secreted in response to
fatty acids in the gastric tract. However, the length of the
fatty acids plays a critical role, as it was found that fatty
acids shorter than C12 [112] do not stimulate the secretion
of cholecystokinin [112]. This would suggest that short chain
fatty acids may provide a source of energy without inhibiting
autophagy. The role of dietary composition that may supply
metabolic substrates with minimum impact on autophagic
processes should therefore be investigated in future studies.
In addition, intensive insulin therapy may also play a
role in derailing autophagy. A high blood glucose level is an
independent marker for increased incidence of infection and
clinical outcome in intensive care patients [113], supporting
the notion that insulin therapy may lower blood glucose and
enhance survival. However, it is not clear whether high glu-
cose levels represent amore aggravated condition, or whether
high glucose levels lead to the development of various
pathologies. It was found in earlier studies that controlling
glucose levels via aggressive insulin therapy (IT) resulted in
clinical benefits in intensive care patients [24]. Yet, a number
of concerns have been raised regarding the validity of this
trial [114]. Indeed, a subsequent trial was terminated ahead
of schedule due to increased adverse effects and in particular
an increase in complications resulting from hypoglycaemia
in patients receiving IT [115]. In this regard, permissive
underfeeding may also avoid further exacerbate already ele-
vated glucose levels without the need for coadministration of
insulin. In addition, we suspect that these occasional adverse
effects may result from insulin’s ability to inhibit autophagy
via the mTOR signalling pathway [116]. Thus, permissive
underfeeding may represent a superior form of nutritional
support by both upregulating autophagy and avoiding the
further increasing glycaemic index via nutritional support.
There is also a need to elucidate the numerous roles that
autophagy plays in a variety of cells over the course of the
disease. Previous studies [117, 118] have identified an early
upregulation of autophagy in proliferating T cells. Indeed,
inhibition of mTOR results in an enhanced T cell mediated
immune response and enhanced immune cell memory [119],
clearly implicating the role of mTOR in T cell function.
However, a recent study [120] where a conditional knock-
out systemwas deployed, demonstrated, contrary to previous
findings, that autophagy is not upregulated in CD8 cells dur-
ing the initial phase of an infection. From day 8, autophagy is
robustly upregulated; yet, at this point (day 8), the virus had
already been cleared. Thus, the stimulus for SAA is removed
at a time when autophagy is upregulated, indicating that
autophagy plays a continuous role in the developing disease
state and that SAA is not the only mechanism by which
cells induce autophagy. Moreover, the function of autophagy
in this context seems to be primarily involved in T cell
survival by means of a metabolic shift towards fatty acid
metabolism.Thus, although autophagy plays a crucial role in
viral control (by promoting cell survival of memory T cells),
this process must be independent of SAA and thus does not
support an interpretation of SAA as the “autophagic trigger.”
Furthermore, it has been demonstrated that T cells exhibit
pronouncedmetabolic plasticity [121], whichmay assist these
cells in surviving the range of environments they encounter as
migrating cells. Collectively, these observations suggest that
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though autophagy has an important function in various
immunological contexts, these autophagic processes are
active, independent of SAA.
Elucidation of autophagic circuits may also be of interest,
both in understanding pathogen subversion and to optimise
nutritional support. A low ATP : AMP ratio upregulates
AMPK, which upregulates autophagy, whereas low AAs
inhibit mTOR, a potent inhibitor of autophagy [122]. Thus,
autophagy may be upregulated by inhibition of mTOR, as
a result of either AA starvation, or mild energy stress. It is
thus possible that autophagy may be preferentially induced
by different nutritional triggers, though it should be noted
that these processes are not mutually exclusive. It is also
well appreciated that animals are capable of “self-medicating”
by selecting food sources with specific properties in order
to rid themselves of various diseases [123]. Indeed, altered
food preference has also been reported in invertebrates.
Two groups have independently observed that African army-
worms prefer and exhibit increased survival when fed a diet
with a higher protein-to-glucose ratio during bacterial [7]
or viral [8] infections. This suggests that AMPK-activated
autophagy may possibly be more important in invertebrates
(whereas AA might be the putative autophagic “trigger” in
vertebrates). Alternatively, it is possible that invertebrates,
during an infection, metabolise AAs as fuelled source, thus
increasing ammonia levels with a subsequent increase in
autophagy [80]. In fact, a similar mechanism has been
observed in a clinical setting: it was shown that LPS impaired
the hepatic removal of ammonia via ureagenesis, which
might explain the increase in ammonia observed in patients
during sepsis [124]. It is tempting to speculate that such a
“metabolic dysfunction” is in fact a strategy to elevate ammo-
nia levels slightly, thus increasing the stimuli for upregulating
autophagy systemically. Future studies may elucidate the
functional value of substrate utilisation, as well as the accu-
mulation of metabolic waste or intermediates in regulating
autophagic processes.
Finally, the fact that pathogens have evolved strategies
for subverting autophagic process necessitate careful study
designs that measure autophagy flux [125]. However, an
increase in autophagic elements such as vesicles may indicate
an increase in autophagic activity. It may also signify a defect
in the autophagic process, such as an inability of lysosomes
to fuse with phagosomes, and it may be a direct result of
pathogen subversion of autophagic process. Moreover, vari-
ous proteins involved in autophagy are also degraded by the
autophagic process itself [126]; thus, immunoblotting of key
proteins may give rise to misleading results.
7. Conclusion
The prevalence of SAA across various species suggests that
avoiding feeding during an infection is an evolutionary
conserved response and consequently must represent an
adaptive response. Yet, the metabolic demand of mobilis-
ing an immune response motivates the implementation of
aggressive nutritional support. Clinical trials and results from
animal studies have not consistently demonstrated an advan-
tage of nutritional supplementation. Similarly, as outlined in
our introduction, a mechanistic justification for SAA as a
beneficial process has not been conclusively identified. The
role of SAA as a strategy for upregulating autophagy not only
provides a rational basis for explaining the clinical value of
permissive underfeeding, but also explains the contrasting
results between studies: some patients may benefit from
autophagy-mediated cell survival and the antipathogenic
effects of this process, whereas some would not. Indeed, in
the context of some pathogens, upregulating autophagy may
in fact be detrimental. Stratifying patient groups according to
the trauma or infectious agents involved may provide insight
into the context in which aggressive nutritional support
may be warranted and where permissive underfeeding may
provide a superior strategy. Finally, there is a need to optimise
scheduling when nutritional support is introduced. It is likely
that patients would benefit most from nutritional support if
administered during the resolution phase, where a shift from
catabolic to anabolic metabolism is observed.
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